| Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision |
pharmaceutical_companies:iecure [2023/05/22 09:41]
liam [Personnel] | pharmaceutical_companies:iecure [2023/05/22 09:46] (current)
liam |
|---|
| | [[:David Garrett]] | Chief Financial Officer | [[Dynacure]], [[Nabriva Therapeutics]], [[Covis Pharmaceuticals]], [[Auxilium Pharmaceuticals]], [[ViroPharma]], [[:KPMG]] | | | [[:David Garrett]] | Chief Financial Officer | [[Dynacure]], [[Nabriva Therapeutics]], [[Covis Pharmaceuticals]], [[Auxilium Pharmaceuticals]], [[ViroPharma]], [[:KPMG]] | |
| | [[:Gabriel Cohn]] | Chief Medical Officer | [[Homology Medicines]], [[AVROBIO]], [[OvaScience]], [[Shire]], [[:American College of Medical Genetics and Genomics]], [[:American College of Obstetrics and Gynecology]] (ACOG), [[:Baystate Medical Center]], [[:Tufts University School of Medicine]] | | | [[:Gabriel Cohn]] | Chief Medical Officer | [[Homology Medicines]], [[AVROBIO]], [[OvaScience]], [[Shire]], [[:American College of Medical Genetics and Genomics]], [[:American College of Obstetrics and Gynecology]] (ACOG), [[:Baystate Medical Center]], [[:Tufts University School of Medicine]] | |
| | | [[:George Diaz]] | VP, Therapeutic Area Lead, Urea Cycle Disorders | [[:Icahn School of Medicine]] | |
| | | [[:James Wilson]] | Chief Scientific Advisor | [[:Gene Therapy Program]], [[:Orphan Disease Center]], [[:University of Pennsylvania]], [[:Health Through Fitness in Orphan Diseases]] | |
| | | [[:Michael Mitchell]] | Scientific Advisor | [[:University of Pennsylvania School of Engineering and Applied Science]], [[:Gene Therapy Program]], [[:Massachusetts Institute of Technology]] | |
| | |
| ===== External links ===== | ===== External links ===== |
| |
| | * [[https://www.crunchbase.com/organization/iecure/company_financials|Crunchbase]] |
| * [[https://www.linkedin.com/company/iecure/|LinkedIn]] | * [[https://www.linkedin.com/company/iecure/|LinkedIn]] |
